File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/s40265-024-02064-x
- Scopus: eid_2-s2.0-85197468161
- Find via
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Article: New and Evolving Treatments for Neurologic Dysphagia
Title | New and Evolving Treatments for Neurologic Dysphagia |
---|---|
Authors | |
Issue Date | 2-Jul-2024 |
Publisher | Springer |
Citation | Drugs, 2024 How to Cite? |
Abstract | Despite swallowing being a frequently performed daily function, it is highly complex. For a safe swallow to occur, muscles within the head, neck, and thorax need to contract in a concerted pattern, controlled by several swallowing centers at multiple levels of the central nervous system, including the midbrain, cerebral cortex, and cerebellum in addition to five cranial nerves. Dysphagia, or difficulty swallowing, is caused by a long list of pathologic processes and diseases, which can interfere with various stages along the swallowing sensorimotor pathway. When present, dysphagia leads to increased mortality, morbidity, hospital length of stay, and reduced quality of life. Current dysphagia management approaches, such as altering the texture and consistency of foods and fluids and teaching patients rehabilitative exercises, have been broadly unchanged for many years and, in the case of texture modification, are of uncertain effectiveness. However, evidence is emerging in support of new medication-based and neuromodulatory treatment approaches. Regarding medication-based therapies, most research has focused on capsaicinoids, which studies have shown are able to improve swallowing in patients with post-stroke dysphagia. Separately, albeit convergently, in the field of neuromodulation, there is a growing and positive evidential base behind three non-invasive brain stimulation techniques: repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (TDCS), and pharyngeal electrical stimulation (PES). Should some or all of these emerging therapies fulfill their promise, dysphagia-related patient outcomes may be improved. This paper describes the current state of our understanding regarding new medication and neuromodulation-based neurogenic oropharyngeal dysphagia treatments |
Persistent Identifier | http://hdl.handle.net/10722/344774 |
ISSN | 2023 Impact Factor: 13.0 2023 SCImago Journal Rankings: 2.352 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sasegbon, Ayodele | - |
dc.contributor.author | Cheng, Ivy | - |
dc.contributor.author | Labeit, Bendix | - |
dc.contributor.author | Lapa, Sriramya | - |
dc.contributor.author | Rommel, Nathalie | - |
dc.contributor.author | Hamdy, Shaheen | - |
dc.date.accessioned | 2024-08-12T04:07:20Z | - |
dc.date.available | 2024-08-12T04:07:20Z | - |
dc.date.issued | 2024-07-02 | - |
dc.identifier.citation | Drugs, 2024 | - |
dc.identifier.issn | 0012-6667 | - |
dc.identifier.uri | http://hdl.handle.net/10722/344774 | - |
dc.description.abstract | <p>Despite swallowing being a frequently performed daily function, it is highly complex. For a safe swallow to occur, muscles within the head, neck, and thorax need to contract in a concerted pattern, controlled by several swallowing centers at multiple levels of the central nervous system, including the midbrain, cerebral cortex, and cerebellum in addition to five cranial nerves. Dysphagia, or difficulty swallowing, is caused by a long list of pathologic processes and diseases, which can interfere with various stages along the swallowing sensorimotor pathway. When present, dysphagia leads to increased mortality, morbidity, hospital length of stay, and reduced quality of life. Current dysphagia management approaches, such as altering the texture and consistency of foods and fluids and teaching patients rehabilitative exercises, have been broadly unchanged for many years and, in the case of texture modification, are of uncertain effectiveness. However, evidence is emerging in support of new medication-based and neuromodulatory treatment approaches. Regarding medication-based therapies, most research has focused on capsaicinoids, which studies have shown are able to improve swallowing in patients with post-stroke dysphagia. Separately, albeit convergently, in the field of neuromodulation, there is a growing and positive evidential base behind three non-invasive brain stimulation techniques: repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (TDCS), and pharyngeal electrical stimulation (PES). Should some or all of these emerging therapies fulfill their promise, dysphagia-related patient outcomes may be improved. This paper describes the current state of our understanding regarding new medication and neuromodulation-based neurogenic oropharyngeal dysphagia treatments<br></p> | - |
dc.language | eng | - |
dc.publisher | Springer | - |
dc.relation.ispartof | Drugs | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.title | New and Evolving Treatments for Neurologic Dysphagia | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/s40265-024-02064-x | - |
dc.identifier.scopus | eid_2-s2.0-85197468161 | - |
dc.identifier.eissn | 1179-1950 | - |
dc.identifier.issnl | 0012-6667 | - |